Total offers pharma processing and packaging solutions
Interphex Hub will stage series of free seminars with top industry speakers
Further highlights will be a series of dedicated free-to-attend seminars in both the Packaging Innovation and Interphex hubs.
Top pharmaceutical companies and specialist equipment suppliers have been confirmed as speakers for the Interphex Hub seminars. Leading names taking part in the seminar programme, sponsored by Bürkert Fluid Control Systems and chaired by Mike Warren, formerly of Niro Pharma, include GlaxoSmithKline, R5 Pharmaceuticals, Atacama Labs, Upperton, Oystar Manesty, Cognex, Hapa and Pharma Tech.
Taking place over the three days of the show, topics will include anticounterfeiting and mass serialisation, Track & Trace technologies, 2D data matrix codes, new technologies for formulation development and GMP manufacture, and a new system for the online monitoring of tablet coating thickness.
‘As a strong Reed Exhibitions brand known around the world, Interphex offers the ideal platform for companies to demonstrate their latest solutions to a wide variety of packaging and production challenges,’ said Ian Crawford, Group Exhibition Director. ‘The seminar programme is an excellent focal point for the Hub and promises to deliver some very interesting presentations and stimulating debates.’
You may also like
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model